S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 121 to 180 of 246

Issue Date	Title / Author(s) / Citation	File
2013-06	RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib Min, Ahrum; Im, Seock-Ah; Yoon, Young-Kwang; Song, Sang-Hyun; Nam, Hyun-Jin; Hur, Hyung-Seok; Kim, Hwang-Phill; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Kim, Woo-Ho; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.12 No.6, pp.865-877	DOI
2013-07	Survival Outcomes and Prognostic Factors of Transcatheter Arterial Chemoembolization for Hepatic Neuroendocrine Metastases Hur, Saebeom; Chung, Jin Wook; Kim, Hyo-Cheol; Oh, Do-Youn; Lee, Se-Hoon; Bang, Yung-Jue; Kim, Woo Ho Journal of Vascular and Interventional Radiology, Vol.24 No.7, pp.947-956	DOI
2013-07	HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.1, pp.109-115	DOI
2013-07	Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer Keam, Bhumsuk; Im, Seock-Ah; Lim, Yoojoo; Han, Sae-Won; Moon, Hyeong-Gon; Oh, Do-Youn; Cho, Nariya; Lee, Se-Hoon; Han, Wonshik; Moon, Woo Kyung; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young Annals of Surgical Oncology, Vol.20 No.7, pp.2242-2249	DOI
2013-07	OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells Kim, Mi-Jung; Nam, Hyun-Jin; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.335 No.1, pp.145-152	DOI
2013-09	Adjuvant and Neoadjuvant Therapy for Gastric Cancer Oh, Do-Youn; Bang, Yung-Jue Current Treatment Options in Oncology, Vol.14 No.3, pp.311-320	DOI
2013-10	Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival Kang, Eun Joo; Im, Seock-Ah; Oh, Do-Youn; Han, Sae-Won; Kim, Jin-Soo; Choi, In Sil; Kim, Jin Won; Kim, Yu Jung; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Lee, Keun-Wook Gastric Cancer, Vol.16 No.4, pp.581-589	DOI
2013-11	Nomogram Prediction of Survival and Recurrence in Patients With Extrahepatic Bile Duct Cancer Undergoing Curative Resection Followed by Adjuvant Chemoradiation Therapy Song, Changhoon; Kim, Kyubo; Chie, Eui Kyu; Kim, Jin Ho; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.87 No.3, pp.499-504	DOI
2013-11	Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jin-Soo; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.5, pp.1023-1029	DOI
2013-12	The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer Lee, Joo Ho; Chie, Eui Kyu; Kim, Kyubo; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. BMC Cancer, Vol.13, p. 576	view file DOI
2013-12	Clinical Implications of VEGF, TGF-beta 1, and IL-1 beta in Patients with Advanced Non-small Cell Lung Cancer Kim, Ji-Won; Koh, Youngil; Kim, Dong-Wan; Ahn, Yong-Oon; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.45 No.4, pp.325-333	DOI
2013-12	The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer Lee, Joo Ho; Chie, Eui Kyu; Kim, Kyubo; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W BMC Cancer Vol.13, pp. 1-9	view file link
2014-01	Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker Kim, Jin Won; Im, Seock-Ah; Kim, Min A.; Cho, Hyun Jin; Lee, Dae Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk-Joon; Kim, Tae-You; Yang, Han-Kwang; Kim, Woo Ho; Bang, Yung-Jue International Journal of Cancer, Vol.134 No.1, pp.72-80	DOI
2014-07	A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HIVI30181A, in Patients with Advanced Solid Cancer Lee, Hyun Jung; Heo, Dae-Seog; Cho, Joo-Youn; Han, Sae-Won; Chang, Hye-Jung; Yi, Hyeon-Gyu; Kim, Tae-Eun; Lee, Se-Hoon; Oh, Do-Youn; Im, Seock-Ah; Jang, In-Jin; Bang, Yung-Jue Cancer Research and Treatment, Vol.46 No.3, pp.234-242	DOI
2014-07	The Impact of Body Mass Index Dynamics on Survival of Patients With Advanced Pancreatic Cancer Receiving Chemotherapy Choi, Younak; Kim, Tae-Yong; Lee, Kyung-hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Pain and Symptom Management, Vol.48 No.1, pp.13-25	DOI
2014-07	Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy Lee, Hyun Jung; Kim, Dae Young; Keam, Bhumsuk; Lee, Jeong Hoon; Han, Sae-Won; Oh, Do-Youn; Yoon, Jung Hwan; Kim, Tae-You; Kim, Yu Jung; Lee, Keun Wook; Kim, Jin-Wook; Jeong, Sook-Hyang; Lee, Jong Seok; Kim, Jee Hyun; Im, Seock-Ah Breast Cancer, Vol.21 No.4, pp.387-393	DOI
2014-07	A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Han, Wonshik; Kim, Kyubo; Chie, Eui Kyu; Park, In-Ae; Kim, Young Tae; Noh, Dong-Young; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.46 No.3, pp.280-287	DOI
2014-08	Impact of Multimodality Approach for Patients with Leptomeningeal Metastases from Solid Tumors Kwon, Jeanny; Chie, Eui Kyu; Kim, Kyubo; Kim, Hak Jae; Wu, Hong-Gyun; Kim, Il Han; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae-Seog; Bang, Yung-Jue; Ha, Sung W. Journal of Korean Medical Science, Vol.29 No.8, pp.1094-1101	view file DOI
2014-08	Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer Cha, Yongjun; Han, Sae-Won; Seol, Hyesil; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, In Ae; Han, Wonshik; Noh, Dong-Young; Kim, Tae-You Anticancer Research, Vol.34 No.8, pp.4275-4280
2014-09	Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer Lee, Keun-Wook; Kim, Yu Jung; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Choi, In Sil; Kim, Jee Hyun Cancer Chemotherapy and Pharmacology, Vol.74 No.3, pp.447-455	DOI
2014-11	A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma Kim, Dong-Wan; Oh, Do-Youn; Shin, Seong Hoon; Kang, Jin Hyoung; Cho, Byoung Chul; Chung, Joo-Seop; Kim, HyeJin; Park, Keon Uk; Kwon, Jung Hye; Han, Ji-Youn; Kim, Mi-Jung; Bang, Yung-Jue BMC Cancer, Vol.14, p. 795	view file DOI
2014-11	Chemoradiotherapy for Extrahepatic Bile Duct Cancer with Gross Residual Disease after Surgery Park, Hae Jin; Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Anticancer Research, Vol.34 No.11, pp.6685-6690
2015-01	TGF-β suppresses COX-2 expression by tristetraprolin-mediated RNA destabilization in A549 human lung cancer cells Kang, Soyeong; Min, Ahrum; Im, Seock-Ah; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Hyun-Ah; Kim, Hee-Jun; Oh, Do-Youn; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.1, pp.101-109	DOI
2015-01	KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX Lee, Dae-Won; Kim, Kyung Ju; Han, Sae-Won; Lee, Hyun Jung; Rhee, Ye Young; Bae, Jeong Mo; Cho, Nam-Yun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Kim, Tae-You Annals of Surgical Oncology, Vol.22 No.1, pp.187-194	DOI
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Bang, Yung-Jue Breast Cancer Research, Vol.17, p. 33	view file DOI
2015-03	Treatment for unresectable gastric cancer Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue 대한의사협회지, Vol.58 No.3, pp.209-215	DOI
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O’Connor, Mark J O'Connor; Bang, Yung-Jue Breast Cancer Research, 17(1):33	view file DOI
2015-04	Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Joo, Ijin; Ha, Sung W. Cancer Research and Treatment, Vol.47 No.2, pp.274-281	DOI
2015-06	A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer Kim, Jin Won; Choi, In Sil; Kim, Yu Jung; Lee, Kyung-Hun; Lee, Keun-Wook; Kim, Tae-Yong; Han, Sae-Won; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Im, Seock-Ah; Oh, Do-Youn Cancer Chemotherapy and Pharmacology, Vol.75 No.6, pp.1175-1182	DOI
2015-06	Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer Ock, Chan-Young; Lee, Keun-Wook; Kim, Jin Won; Kim, Jin-Soo; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue; Oh, Do-Youn Clinical Cancer Research, Vol.21 No.11, pp.2520-2529	DOI
2015-07	Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX Lee, Dae-Won; Han, Sae-Won; Cha, Yongjun; Rhee, Ye Young; Bae, Jeong Mo; Cho, Nam-Yun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Kang, Gyeong Hoon; Kim, Tae-You Clinical Epigenetics, Vol.7, p. 63	view file DOI
2015-08	Metabolic characteristics of advanced biliary tract cancer using F-18-fluorodeoxyglucose positron emission tomography and their clinical implications Cho, Kyoung-Min; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncologist, Vol.20 No.8, pp.926-933	DOI
2015-10	Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients Lee, Dae-Won; Han, Sae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, Ji Won; Ryoo, Seung-Bum; Jeong, Seung-Yong; Kang, Gyeong Hoon; Park, Kyu Joo; Kim, Tae-You BMC Cancer, Vol.15, p. 690	view file DOI
2015-10	Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma Lee, Kyung-Hun; Lee, Kyoung-Bun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Yi, Nam-Joon; Lee, Kwang-Woong; Suh, Kyung-Suk; Jang, Ja-June; Bang, Yung-Jue BMC Cancer, Vol.15, p. 721	view file DOI
2015-10	Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index Choi, Younak; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue PLoS ONE, Vol.10 No.10, p. e0139749	DOI
2015-10	Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Yuasa, Miyuki; Yanagihara, Yasuo; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.607-615	DOI
2015-10	Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer Oh, Do-Youn; Doi, Toshihiko; Shirao, Kuniaki; Lee, Keun-Wook; Park, Sook Ryun; Chen, Ying; Yang, Liqiang; Valota, Olga; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.687-696	DOI
2015-10	High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy Lim, Yu Jin; Koh, Jaemoon; Kim, Kyubo; Chie, Eui Kyu; Kim, BoKyong; Lee, Kyoung Bun; Jang, Jin-Young; Kim, Sun-Whe; Oh, Do-Youn; Bang, Yung-Jue; Ha, Sung W. Radiotherapy and Oncology, Vol.117 No.1, pp.165-170	DOI
2015-10	The prognostic importance of the number of metastatic lymph nodes for patients undergoing curative resection followed by adjuvant chemoradiotherapy for extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Journal of Gastrointestinal Surgery, Vol.19 No.10, pp.1833-1841	DOI
2015-11	The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn American Journal of Cancer Research, Vol.5 No.11, pp.3376-3388
2015-12	Capecitabine for the treatment of gastric cancer Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue Expert Review of Gastroenterology and Hepatology, Vol.9 No.12, pp.1471-1481	DOI
2016-01	The impact of diabetes mellitus and metformin treatment on survival of patients with advanced pancreatic cancer undergoing chemotherapy Choi, Younak; Kim, Tae-Yong; Oh, Do-Youn; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.171-179	DOI
2016-01	More accurate prediction of metastatic pancreatic cancer patients' survival with prognostic model using both host immunity and tumor metabolic activity Choi, Younak; Oh, Do-Youn; Park, Hyunkyung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue PLoS ONE, Vol.11 No.1, p. A58	DOI
2016-01	Phase I study of CKD-516, a novel vascular disrupting agent, in patients with advanced solid tumors Oh, Do-Youn; Kim, Tae-Min; Han, Sae-Won; Shin, Dong-Yeop; Lee, Yun Gyoo; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Tae-You; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.28-36	DOI
2016-02	Pertuzumab in gastrointestinal cancer Oh, Do-Youn; Bang, Yung-Jue Expert Opinion on Biological Therapy, Vol.16 No.2, pp.243-253	DOI
2016-03	Survival outcomes according to adjuvant treatment and prognostic factors including host immune markers in patients with curatively resected ampulla of vater cancer Ha, Hye Rim; Oh, Do-Youn; Kim, Tae-Yong; Lee, KyoungBun; Kim, Kyubo; Lee, Kyung-Hun; Han, Sae-Won; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Bang, Yung-Jue PLoS ONE, Vol.11 No.3, p. e0151406	DOI
2016-03	Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy Kim, Hyori; Youk, Jeonghwan; Yang, Yaewon; Kim, Tae-Yong; Min, Ahrum; Ham, Hye-Seon; Cho, Seongcheol; Lee, Kyung-Hun; Keam, Bhumsuk; Han, Sae-Won; Oh, Do-Youn; Ryu, Han Suk; Han, Wonshik; Park, In Ae; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Journal of Cancer Research and Clinical Oncology, Vol.142 No.3, pp.707-714	DOI
2016-04	A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09 Lee, Ki Hyeong; Kim, Ji-Yeon; Lee, Moon Hee; Han, Hye Sook; Lim, Joo Han; Park, Keon Uk; Park, In Hae; Cho, Eun Kyung; Yoon, So Young; Kim, Jee Hyun; Choi, In Sil; Park, Jae Hoo; Choi, Young Jin; Kim, Hee-Jun; Jung, Kyung Hae; Kim, Si-Young; Oh, Do-Youn; Im, Seock-Ah Supportive Care in Cancer, Vol.24 No.4, pp.1709-1717	DOI
2016-04	Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer Ock, Chan-Young; Oh, Do-Youn; Lee, Joongyub; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Gastric Cancer, Vol.19 No.2, pp.597-606	DOI
2016-04	Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications Ock, Chan-Young; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.19 No.2, pp.421-430	DOI
2016-04	Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer patients in stage II in the 7th TNM but stage I in the 6th TNM system? Lee, Kyung-Goo; Lee, Hyuk-Joon; Oh, Seung-Young; Yang, Jun-Young; Ahn, Hye-Seong; Suh, Yun-Suhk; Kong, Seong-Ho; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Lee, Kuhn Uk; Kim, Woo Ho; Bang, Yung-Jue; Yang, Han-Kwang Annals of Surgical Oncology, Vol.23 No.4, pp.1234-1243	DOI
2016-06	Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Nutrition and Cancer, Vol.68 No.5, pp.750-755	DOI
2016-07	Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer Cha, Yongjun; Kim, Kyung-Ju; Han, Sae-Won; Rhee, Ye Young; Bae, Jeong Mo; Wen, Xianyu; Cho, Nam-Yun; Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Kang, Gyeong Hoon; Kim, Tae-You British Journal of Cancer, Vol.115 No.2, pp.164-171	DOI
2016-07	Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX Kim, Mi-Jung; Han, Sae-Won; Lee, Dae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Kim, Se Hyung; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Research and Treatment, Vol.48 No.3, pp.990-997	DOI
2016-07	Concurrent chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: A retrospective cohort study Choi, Younak; Oh, Do-Youn; Kim, Kyubo; Chie, Eui Kyu; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.3, pp.1045-1055	DOI
2016-07	Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yang, Yaewon; Im, Seock-Ah; Keam, Bhumsuk; Lee, Kyung-Hun; Kim, Tae-Yong; Suh, Koung Jin; Ryu, Han Suk; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young BMC Cancer, Vol.16, p. 515	DOI
2016-07	Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.158 No.2, pp.233-241	DOI
2016-07	Src as a Therapeutic Target in Biliary Tract Cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524	DOI
2016-08	Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.39 No.4, pp.346-349	DOI

1 2 3 4 5